Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Stoke Therapeutics Inc’s stock clocked out at $7.75, up 2.51% from its previous closing price of $7.56. In other words, the price has increased by $2.51 from its previous closing price. On the day, 0.51 million shares were traded. STOK stock price reached its highest trading level at $7.99 during the session, while it also had its lowest trading level at $7.41.
Ratios:
To gain a deeper understanding of STOK’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.81 and its Current Ratio is at 5.81. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on December 20, 2024, initiated with a Buy rating and assigned the stock a target price of $24.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 18 ’25 when Kaye Edward M. MD sold 10,382 shares for $8.67 per share. The transaction valued at 90,012 led to the insider holds 148,253 shares of the business.
Kaye Edward M. MD sold 8,907 shares of STOK for $73,661 on Mar 19 ’25. The Director now owns 139,346 shares after completing the transaction at $8.27 per share. On Mar 18 ’25, another insider, Ticho Barry, who serves as the CHIEF MEDICAL OFFICER of the company, sold 3,884 shares for $8.67 each. As a result, the insider received 33,674 and left with 63,962 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STOK now has a Market Capitalization of 419102176 and an Enterprise Value of 206977472. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.47 while its Price-to-Book (P/B) ratio in mrq is 1.83. Its current Enterprise Value per Revenue stands at 5.662 whereas that against EBITDA is -2.087.
Stock Price History:
The Beta on a monthly basis for STOK is 1.20, which has changed by -0.3387372 over the last 52 weeks, in comparison to a change of 0.07455289 over the same period for the S&P500. Over the past 52 weeks, STOK has reached a high of $17.58, while it has fallen to a 52-week low of $5.35. The 50-Day Moving Average of the stock is -7.47%, while the 200-Day Moving Average is calculated to be -33.70%.
Shares Statistics:
It appears that STOK traded 852.69K shares on average per day over the past three months and 904380 shares per day over the past ten days. A total of 54.03M shares are outstanding, with a floating share count of 41.65M. Insiders hold about 22.99% of the company’s shares, while institutions hold 89.77% stake in the company. Shares short for STOK as of 1743379200 were 12087490 with a Short Ratio of 14.18, compared to 1740700800 on 11174208. Therefore, it implies a Short% of Shares Outstanding of 12087490 and a Short% of Float of 33.040002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
